Results - Announcements
OneSource Specialty Pharma Ltd share price rallied 13.96% to Rs 1591.25 after the company's net profit soared by 129.92% to Rs 57.48 crore, while revenue from operations gained 14.97% to Rs 516.24 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, rising 4.06%. It has marginally improved by 3.17% over last one week and edged lower by 0.26% in last one month while the market capitalization of OneSource Specialty Pharma Ltd has sharply increased by 17.77% and 5.50% in the same period respectively.
Profit before tax (PBT) of OneSource Specialty Pharma Ltd stood at Rs 52.87 crore in Q3 FY26, jumping 821.08% year-on-year, and rallying 160.57% quarter-on-quarter. EBITDA came in at Rs 162 crore, surging by 56.91% YoY and expanding by 35.79% sequentially.
Total expenses saw a slight increase of 7.69% to Rs 428.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 152.25 crore, growing marginally by 7.83% YoY, while employee benefits expense was at Rs 77.58 crore, witnessing a strong rise of 12.96% YoY.
For the TTM ended FY26, revenue from operations softened by 1.61% to Rs 1421.59 crore, while net profit surged by 327.08% to Rs 73.8 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 45325% to Rs 289.2 crore, and PBT soared 37.11% to Rs 91.96 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 8.52 crore in FY26, as against Rs 67.85 crore in FY25.
OneSource Specialty Pharma Ltd crashed 11.98% in last one year, outperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.